Elicio Therapeutics (NASDAQ:ELTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Elicio Therapeutics (ELTX) operate in?

Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Elicio Therapeutics Stock (NASDAQ: ELTX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 25.87K
Day Range	- - -
52 Wk Range	2.96 - 11.45
Market Cap	$69.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	1.03%
Days to Cover	4.54

Recent News

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?

Elicio Therapeutics announced promising preliminary data from the AMPLIFY-7P Phase 1a study of ELI-002 7P, showing extended median disease-free survival in patients with mKRAS-driven solid tumors.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Oct 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 25.87K
Day Range	- - -
52 Wk Range	2.96 - 11.45
Market Cap	$69.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	1.03%
Days to Cover	4.54

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Elicio Therapeutics (ELTX) stock?

You can purchase shares of Elicio Therapeutics (NASDAQ:ELTX) through any online brokerage.

View our list of the best stock brokerages

Who are Elicio Therapeutics (ELTX) competitors?

Other companies in Elicio Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP), Inovio Pharmaceuticals (NASDAQ:INO) and Adicet Bio (NASDAQ:ACET).

What is the forecast, or price target, for Elicio Therapeutics (ELTX) stock?

Elicio Therapeutics has a consensus price target of $9.50.

What is the current price for Elicio Therapeutics (ELTX)?

The stock price for Elicio Therapeutics (NASDAQ: ELTX) is $6.25 last updated January 17, 2025 at 3:59 PM EST.

Does Elicio Therapeutics (ELTX) pay a dividend?

There are no upcoming dividends for Elicio Therapeutics.

When is Elicio Therapeutics (NASDAQ:ELTX) reporting earnings?

Elicio Therapeutics’s Q4 earnings are confirmed for Friday, March 28, 2025.

Is Elicio Therapeutics (ELTX) going to split?

There is no upcoming split for Elicio Therapeutics.

What sector and industry does Elicio Therapeutics (ELTX) operate in?

Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Elicio Therapeutics

Elicio Therapeutics (ELTX) Forecast